Research | OneLook Acronym Finder |
Serial Number | 98214461 |
Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
Attorney Name | Kristin H. Altoff |
Attorney Docket Number | 131399-0003 |
2023-10-09 | Application Filed |
2023-10-12 | Location: NEW APPLICATION PROCESSING |
2023-10-12 | Status: Live/Pending |
2023-10-12 | Transaction Date |
Owner: | ReNAgade Therapeutics Management, Inc. |
Address | 640 Memorial Drive, Suite 2300 Cambridge DE 02139 |
Legal Entity Type | Corporation |
Legal Entity State | DE |
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
International Codes: | 1 |
U.S. Codes: | 001,005,006,010,026,046 |
International Codes: | 5 |
U.S. Codes: | 005,006,018,044,046,051,052 |
International Codes: | 42 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
GS0051 | Pharmaceutical preparations, lipids, lipid nanoparticles, lipid formulations, nucleic acid molecules, enzymes, polypeptides, and compounds/agents for medical use; pharmaceutical preparations and therapeutic agents, namely, for RNA, gene therapy and mRNA regulation; pharmaceutical and biological preparations for medical use for the treatment of genetic and genomic disorders by gene therapy and mRNA regulation for use in human and animal therapeutics; pharmaceutical preparations, namely, therapeutic pharmaceuticals developed through genome modifications for the prevention and treatment of genomic disorders in humans and animals; pharmaceutical preparations for gene therapy and mRNA regulation |
Description | Date | Event Coding |
---|---|---|
NEW APPLICATION ENTERED | 2023-10-12 | 1 NWAP I:Incoming Correspondence |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | 2023-10-15 | 2 NWOS I:Incoming Correspondence |
ASSIGNED TO EXAMINER | 2024-04-26 | 3 DOCK D:Assigned to Examiner |
NON-FINAL ACTION WRITTEN | 2024-04-30 | 4 CNRT R:Renewal |
NON-FINAL ACTION E-MAILED | 2024-04-30 | 5 GNRT F:First Action |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2024-04-30 | 6 GNRN O:Outgoing Correspondence |
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | 2024-07-15 | 7 XELR I:Incoming Correspondence |
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | 2024-07-15 | 8 XELG O:Outgoing Correspondence |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.